APA (7th ed.) Citation

A, Z., ND, R., Z, Z., A, K., J, D., R, T., . . . T, H. (2026). Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.04.22.720179

Chicago Style (17th ed.) Citation

A, Zerva, et al. "Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib Leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137." BioRxiv : The Preprint Server for Biology 2026. https://doi.org/10.64898/2026.04.22.720179.

MLA (9th ed.) Citation

A, Zerva, et al. "Macrocyclization of Broad-Spectrum Kinase Inhibitor Bosutinib Leads to Potent and Selective Quinoline-based HIPK4 Inhibitor AZ137." BioRxiv : The Preprint Server for Biology, 2026, https://doi.org/10.64898/2026.04.22.720179.